Skip to content

Gait Training using Honda Walking Assist for Parkinson's disease

Stride Management Assist Gait Training for Parkinson's Disease: An Open-Label, Randomized Controlled Study - SMATPD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000040131
Enrollment
14
Registered
2020-04-11
Start date
2017-10-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

Patients undergo over-ground gait training using SMA of 30 minutes per session, ten times for 3 months outdoors near the participants&#39
home. Patients undergo over-ground gait training of 30 minutes per session, ten times for 3 months near the participants&#39
home.

Sponsors

Kawashima Neurology Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We include out-patients with PD fulfilled MDS clinically established PD criteria, who are able to walk independently with/without walking aides and patients have the following conditions; 1. Hoehn and Yahr stage is 2-4 degrees in on state, 2. UPDRS Part III score is 10 points or more in on state, 3. MMSE score is not lower than 26 points, and 4. The patient does not show an unpredictable off state.

Exclusion criteria

Exclusion criteria: We exclude out-patients with PD fulfilled MDS clinically established PD criteria, who are unable to walk with walking aids, or patients who have the following conditions; 1. Hoehn and Yahr stage is 1 or 5 degrees in on state. 2. UPDRS Part III score is below 10 points in on state, 3. MMSE score is below 26 points, or 4. The patient shows an unpredictable off state.

Design outcomes

Primary

MeasureTime frame
Primary outcome is walking distance in 3-Minute Walk Test (3MWT). We measure it at baseline and at post-intervention of 10 sessions for 3 months.

Secondary

MeasureTime frame
Secondary outcomes are 10-Meter Walk Test, physiological cost index (PCI) in 3MWT, Berg Balance Scale, Functional Reach Test, UPDRS part III, MDS-UPDRS 3.11 (freezing of gait), Freezing of Gait Questionnaire, PDQ-39, EQ-5D-5L and gait and posture analysis using Mobile Motion Visualizer. We measure them at baseline and at post-intervention of 10 sessions for 3 months.

Countries

Japan

Contacts

Public ContactNoriko Kawashima

Kawashima Neurology Clinic Neurology

nkawashi@pf7.so-net.ne.jp81-466-55-1358

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026